Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹86 Cr.
Stock P/E
12.7
P/B
0.7
Current Price
₹333.9
Book Value
₹ 463.9
Face Value
10
52W High
₹435.8
52W Low
₹ 300
Dividend Yield
3.89%

Cravatex Overview

Business

Cravatex Ltd. is an Indian trading company primarily engaged in the distribution and retail of international sportswear, lifestyle products, and fitness equipment brands. The company acts as an exclusive distributor and licensee for various global brands in the Indian market. Its core business model involves securing distribution rights, managing supply chains, and selling these products through a multi-channel approach, including exclusive brand stores, multi-brand outlets, large format retail chains, and e-commerce platforms. The company makes money through the margins on products sold and potentially through licensing fees.

Revenue Mix

While exact revenue contribution percentages are not consistently provided in public domain for the most granular breakdown, Cravatex Ltd. broadly operates in two primary segments:

Sportswear & Lifestyle: This segment involves the distribution and retail of apparel, footwear, and accessories for international sports and lifestyle brands such as Lotto, Umbro, Russell Athletic, and Le Coq Sportif.

Fitness Equipment: This segment focuses on the distribution and sales of various fitness equipment for home and commercial use.

Industry

Cravatex Ltd. operates within the highly competitive Indian retail and distribution industry, specifically targeting the sportswear, lifestyle, and fitness equipment markets. This industry is characterized by a growing consumer base, increasing health consciousness, and the presence of both international and domestic brands. Cravatex positions itself as an established and experienced partner for international brands looking to enter or expand in the Indian market, leveraging its extensive distribution network and retail presence. It competes with direct operations of global brands, other multi-brand distributors, and unorganized retail.

MOAT

Cravatex Ltd.'s competitive advantages include:

Established Distribution Network: A long-standing and extensive distribution network across India, crucial for reaching diverse markets.

Brand Relationships: Decades-long relationships and exclusive distribution agreements with several international brands, which can be difficult for new entrants to replicate.

Market Expertise: Deep understanding of the Indian consumer market, retail dynamics, and regulatory environment.

Supply Chain Management: Experience in managing complex import and distribution logistics for international products.

Growth Drivers

Key factors that can drive Cravatex Ltd.'s growth over the next 3-5 years include:

Rising Disposable Incomes: Increasing affluence in India leads to higher consumer spending on discretionary items like sportswear and fitness equipment.

Health & Fitness Awareness: Growing awareness about health, wellness, and active lifestyles drives demand for related products.

Urbanization & Organized Retail Growth: Expansion of modern retail formats, malls, and e-commerce penetration in Tier 2/3 cities.

New Brand Partnerships: Ability to secure distribution rights for additional popular international brands.

E-commerce Expansion: Leveraging online channels to reach a wider customer base and drive sales.

Risks

Dependence on Key Brands: The business is highly dependent on its relationships and distribution rights for specific international brands. Loss of these rights or a brand deciding to enter India directly could significantly impact revenue.

Intense Competition: Competition from direct brand operations, other distributors, and domestic players can squeeze margins and market share.

Inventory Management: Risks associated with managing large inventory, including obsolescence, slow-moving stock, and working capital requirements.

Economic Downturn: A slowdown in the Indian economy could reduce discretionary consumer spending on sportswear and fitness equipment.

Supply Chain Disruptions: Geopolitical events, pandemics, or logistical issues can disrupt the import and distribution of products.

Foreign Exchange Volatility: As an importer, currency fluctuations can impact costs and profitability.

Management & Ownership

Cravatex Ltd. is promoted and managed by the Jhaveri family, which has a long history with the company. The management brings extensive experience in the Indian textile and retail sectors. The ownership structure typically includes a significant promoter holding, common in Indian family-run businesses, indicating aligned long-term interests with the company's performance.

Outlook

Cravatex Ltd. operates in a promising market driven by India's demographic dividend and increasing consumer awareness of health and lifestyle. Its established distribution network and long-standing brand partnerships provide a solid foundation. The bull case rests on the continued growth of the Indian consumer market, successful expansion of existing brand sales, and the potential addition of new reputable international brands to its portfolio, coupled with effective penetration into Tier 2/3 cities and e-commerce.

However, the company faces inherent risks such as potential loss of key distribution rights, intense competition from direct brand entries, and challenges in inventory management within a fast-evolving retail landscape. The bear case would involve losing significant brand partnerships, inability to adapt to changing consumer preferences or retail trends, or a severe economic downturn impacting discretionary spending. Overall, Cravatex is positioned to benefit from secular trends in India's consumer market but must navigate competitive pressures and maintain strong brand relationships to ensure sustained growth.

Cravatex Share Price

Live · BSE / NSE · Inception: 1951
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Cravatex Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 51 26 55 32 61 23 51 37 40 32
Other Income 3 3 2 2 2 5 4 5 3 4
Total Income 53 29 57 35 63 28 55 41 43 37
Total Expenditure 53 28 53 34 60 29 49 39 40 35
Operating Profit 1 1 4 0 3 -1 7 2 3 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 4 -0 2 -1 6 2 2 1
Provision for Tax -0 0 1 -0 1 0 1 0 1 0
Profit After Tax 1 0 3 0 1 -1 5 1 2 0
Adjustments -0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments 1 0 3 0 1 -1 5 1 2 0
Adjusted Earnings Per Share 2 1.9 10.3 1 5.6 -5.3 20.2 5.2 6.2 1.7

Cravatex Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 255 266 356 718 865 532 594 504 203 174 151 160
Other Income 3 4 4 4 5 14 15 12 16 10 17 16
Total Income 257 270 360 722 870 546 610 516 219 184 168 176
Total Expenditure 249 271 361 694 843 544 598 534 210 175 157 163
Operating Profit 8 -1 -1 28 26 2 12 -17 8 8 10 13
Interest 13 11 5 6 14 15 14 14 0 0 0 0
Depreciation 3 3 6 6 15 17 16 16 2 1 2 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 106 0 0 0 0
Profit Before Tax -7 -15 -12 17 -2 -30 -19 58 6 6 9 11
Provision for Tax 1 -1 0 6 2 1 1 -1 1 2 2 2
Profit After Tax -8 -14 -12 11 -5 -31 -20 59 5 5 7 8
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -8 -14 -12 11 -5 -31 -20 59 5 5 7 8
Adjusted Earnings Per Share -30.7 -53.7 -47.7 41.3 -18.2 -118.4 -77 228 18.7 18.7 26.3 33.3

Cravatex Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 36 22 9 20 -1 -28 -50 92 99 106 119
Minority's Interest 0 0 0 -0 71 75 75 0 0 0 0
Borrowings 9 80 83 84 83 84 106 0 0 0 0
Other Non-Current Liabilities 9 8 9 8 45 37 27 2 3 3 2
Total Current Liabilities 120 110 107 188 244 217 205 43 23 31 24
Total Liabilities 175 220 208 299 442 385 365 137 124 141 146
Fixed Assets 28 46 41 41 86 70 55 3 4 4 3
Other Non-Current Assets 5 9 9 11 15 13 15 8 5 5 5
Total Current Assets 142 164 158 247 341 302 295 126 115 131 138
Total Assets 175 220 208 299 442 385 365 137 124 141 146

Cravatex Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 0 7 57 6 7 39 35 38 56 74 75
Cash Flow from Operating Activities 0 35 -13 -5 32 -4 -8 144 19 3 1
Cash Flow from Investing Activities 0 -24 -4 3 -37 21 14 42 -1 -1 3
Cash Flow from Financing Activities 0 38 -34 -0 37 -21 -4 -168 -0 -1 -3
Net Cash Inflow / Outflow 0 50 -51 -2 32 -4 3 18 17 2 1
Closing Cash & Cash Equivalent 0 57 6 4 39 35 38 56 74 75 77

Cravatex Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -30.66 -53.66 -47.74 41.26 -18.24 -118.45 -76.95 228.05 18.68 18.68 26.3
CEPS(Rs) -18.01 -40.51 -25.55 63.44 39.72 -50.96 -13.62 290.52 25.97 24.4 32.14
DPS(Rs) 0 0 1 2 3 3 3 1.5 3 12.5 13
Book NAV/Share(Rs) 138.89 83.09 36.1 76.53 -3.96 -109.44 -192.58 357.42 382.02 411.83 462.18
Core EBITDA Margin(%) 2.27 -1.74 -1.58 3.35 2.46 -2.23 -0.55 -5.93 -3.77 -0.97 -4.23
EBIT Margin(%) 2.04 -1.69 -1.99 3.14 1.33 -2.82 -0.74 14.32 3.24 3.9 5.92
Pre Tax Margin(%) -2.89 -5.7 -3.4 2.35 -0.28 -5.59 -3.12 11.58 3.04 3.67 5.68
PAT Margin (%) -3.11 -5.21 -3.47 1.49 -0.55 -5.76 -3.35 11.7 2.38 2.78 4.5
Cash Profit Margin (%) -1.83 -3.93 -1.86 2.28 1.19 -2.48 -0.59 14.91 3.31 3.63 5.5
ROA(%) -4.68 -7.03 -5.76 4.2 -1.27 -7.4 -5.31 23.51 3.7 3.64 4.74
ROE(%) -19.88 -48.34 -80.11 73.26 -50.28 0 0 276.7 5.05 4.71 6.02
ROCE(%) 4.77 -3.41 -5.24 17.96 7.78 -10.5 -3.59 68.8 6.87 6.62 7.92
Receivable days 105.34 92.45 84.27 64.41 67.43 107.22 84.83 57.77 36.08 39.71 48.74
Inventory Days 75.15 67.17 39.95 30.51 34.9 57.17 55.07 44.71 35.77 23.26 41.71
Payable days 63.82 65.07 68.32 29.81 19.47 32.59 27.99 30.99 40.41 38.15 49.54
PER(x) 0 0 0 6.9 0 0 -4.69 1.4 23.4 18.34 11.6
Price/Book(x) 1.64 4.34 10.61 3.72 -81.81 -2.65 -1.87 0.9 1.14 0.83 0.66
Dividend Yield(%) 0 0 0.26 0.7 0.93 1.03 0.83 0.47 0.69 3.65 4.26
EV/Net Sales(x) 0.48 0.64 0.55 0.26 0.23 0.36 0.37 0.05 0.18 0.08 0.01
EV/Core EBITDA(x) 14.53 -155.28 -146.07 6.54 7.36 79.61 18.55 -1.51 4.37 1.58 0.22
Net Sales Growth(%) 9.54 4.46 33.71 101.7 20.48 -38.49 11.74 -15.26 -59.77 -14.25 -13.17
EBIT Growth(%) -61.12 -186.58 -57.47 418.05 -48.9 -230.38 70.85 1748.93 -90.9 3.31 31.74
PAT Growth(%) -432.15 -74.99 11.02 186.42 -144.22 -549.26 35.03 396.33 -91.81 0.02 40.77
EPS Growth(%) -432.15 -74.98 11.02 186.42 -144.21 -549.31 35.03 396.34 -91.81 0.02 40.77
Debt/Equity(x) 2 6.27 11.26 5.9 -157.02 -5.47 -3.36 0 0 0 0
Current Ratio(x) 1.18 1.49 1.48 1.32 1.4 1.39 1.43 2.95 5.11 4.22 5.62
Quick Ratio(x) 0.71 1.11 1.14 0.87 1.06 1 0.97 2.27 4.64 3.86 4.68
Interest Cover(x) 0.41 -0.42 -1.41 3.99 0.83 -1.02 -0.31 5.22 16.1 16.41 24.6
Total Debt/Mcap(x) 1.22 1.44 1.06 1.59 1.92 2.06 1.79 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -13% -33% -22% -5%
Operating Profit CAGR +25% — +38% +2%
PAT CAGR +40% -51% — —
Share Price CAGR -14% -5% -1% +4%
ROE Average +6% +5% +58% +15%
ROCE Average +8% +7% +17% +9%

Cravatex Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 75 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 25 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 75757575757575757575
FII 0000000000
DII 0000000000
Public 25252525252525252525
Others 0000000000
Total 100100100100100100100100100100

Cravatex Peer Comparison

Cravatex Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Cravatex Pros & Cons

Pros

  • Stock is trading at 0.7 times its book value
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5% over the last 3 years.
  • Debtor days have increased from 38.15 to 49.54days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp